Virtual Care for Frailty After Surgery
(VICTORY Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether virtual care using CloudDX technology, a remote monitoring system, can help people with frailty recover from surgery more effectively than standard care. The goal is to increase the number of days patients spend alive and at home after surgery, reducing hospital visits. Participants will either receive standard post-surgery care or use virtual care tools, such as remote monitoring and daily symptom surveys. Ideal candidates are individuals over 60 diagnosed with frailty and planning elective surgery. The trial aims to find better ways to support frail patients and alleviate hospital capacity issues. As an unphased trial, it offers a unique opportunity to contribute to innovative care solutions for frail patients.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that CloudDX technology is safe for virtual care in frail surgical patients?
Research has shown that CloudDX technology is safe. A previous study in Canada using this technology yielded promising results. Patients experienced 24% fewer drug errors and reported 14% less pain. Additionally, hospital readmissions dropped by 5%. These outcomes indicate that patients receive the technology well and that it can enhance their post-surgery care.
Experts have reviewed studies proving the accuracy of CloudDX's monitoring devices. This accuracy is crucial for obtaining regulatory approval, demonstrating that the technology meets strict safety and effectiveness standards. These findings suggest that CloudDX technology is safe, particularly for individuals requiring additional care after surgery.12345Why are researchers excited about this trial?
Researchers are excited about the Virtual Care approach using CloudDX technology because it brings remote monitoring directly to patients recovering from surgery. Unlike traditional standard care, where patients primarily rely on follow-up visits to their doctors, this method allows continuous health monitoring at home through a cellular-enabled tablet. The use of CloudDX technology enables real-time tracking of vital signs and symptoms, giving healthcare providers the ability to tailor care more precisely to a patient's needs right after they leave the hospital. This approach aims to enhance the recovery experience by catching potential issues early and reducing the need for hospital readmissions.
What evidence suggests that CloudDX technology is effective for improving care for surgical patients with frailty?
Research has shown that CloudDX technology, used by participants in the Virtual Care arm of this trial, holds promise for post-surgery care, particularly for frail patients. One study found that 96% of patients were satisfied with the monitoring program, and 99% were willing to manage their health at home. This technology employs remote monitoring to track vital health signs and symptoms, simplifying health management without frequent hospital visits. Another study confirmed its effectiveness in real-world settings, ensuring it meets the necessary standards for patient care. These findings suggest that CloudDX technology can aid frail surgical patients in recovering more comfortably at home.14678
Who Is on the Research Team?
Sylvie Aucoin, MD
Principal Investigator
The Ottawa Hospital
Are You a Good Fit for This Trial?
The VICTORY trial is for people over 60 with frailty (Clinical Frailty Score >4) who are scheduled for elective surgery and speak English. It's not specified who can't join, but typically those with conditions that could interfere with virtual care or follow-up might be excluded.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive virtual care from the VRAS nursing and anesthesiologist team following surgical discharge, facilitated by Cloud DX software and monitoring equipment.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of quality of life, medication issues, and incidence of post-discharge falls.
Long-term follow-up
Participants' resource use and patient-centered outcomes are monitored up to 1 year post-surgery.
What Are the Treatments Tested in This Trial?
Interventions
- CloudDX technology
Trial Overview
This study tests if virtual care using CloudDX technology improves the number of days older adults with frailty spend at home after planned surgery, compared to standard post-surgical care. Participants will receive either the new virtual care method or usual care.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Intervention group participants will be enrolled in a PVC program prior to admission, including receipt of a cellular-enabled tablet and Cloud DX remote monitoring equipment. Through Cloud DX remote monitoring technology, intervention group participants will receive the following intervention: remote automated monitoring, frailty-tailored daily symptom survey, Katz Index of Independence in Activities of Daily Living survey, FAM-CAM survey, Virtual RN assessment, medications.
The standard care group will receive their post-hospital discharge management in alignment with standard of care at the hospital where they had surgery.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Hospital Research Institute
Lead Sponsor
Published Research Related to This Trial
Citations
1.
accessnewswire.com
accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cloud-dx%E2%80%99s-post-surgical-monitoring-wearable-validated-in-peer-reviewe-676656Cloud DX's Post-Surgical Monitoring Wearable Validated ...
The study assessed regulatory compliance and post-surgery use in monitoring patients' vital signs in real-world conditions. The study found ...
The VICTORY Trial: Virtual, Innovative, Postsurgical Care ...
Through Cloud DX remote monitoring technology, intervention group participants will receive the following intervention: remote automated monitoring, frailty ...
3.
stocktitan.net
stocktitan.net/news/CDXFF/cloud-dx-reports-high-satisfaction-amongst-post-surgical-remote-evp35xf1ygag.htmlCloud DX Reports High Satisfaction Amongst Post-Surgical ...
96% patient satisfaction with remote monitoring program. · 99% of patients are willing to continue managing health vitals at home.
4.
researchgate.net
researchgate.net/figure/The-Cloud-DX-Vitaliti-multibiometric-channel-vital-signs-monitor-Reproduced-with_fig2_324761933The Cloud DX Vitaliti multibiometric channel vital signs ...
The purpose of this study was to evaluate the implementation of a novel Telehealth Home monitoring Enhanced-Frailty And Cardiac Surgery (THE-FACS) intervention ...
5.
proactiveinvestors.co.uk
proactiveinvestors.co.uk/companies/news/968757/cloud-dx-says-post-surgical-monitoring-wearable-validated-in-peer-reviewed-study-968757.htmlCloud DX says post-surgical monitoring wearable ...
The virtual care company said the study assessed regulatory compliance and post-surgery use in monitoring patients' vital signs in real-world ...
Cloud DX Connected Health
Cloud DX delivers comprehensive Remote Patient Monitoring or RPM solutions deployed across North America. What sets Cloud DX apart from other RPM vendors?
Canadian Study Using Cloud DX Technology Proves ...
Results show that virtual care patients saw a 24% reduction in drug errors, up to 14% fewer patients reported pain, and there were 5% fewer re- ...
Leverage RPM for Improved Patient Outcomes in Canada
This technology gives health care providers the ability to detect early signs of complications and optimize medical management.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.